Work

Immunotoxins and Anticancer Drug Conjugate Assemblies: The Role of the Linkage between Components

Year: 2011
Type: review
Abstract: Immunotoxins and antibody-drug conjugates are protein-based drugs combining a target-specific binding domain with a cytotoxic domain. Such compounds are potentially therapeutic against diseases including cancer, and several clinical trials have shown encouraging results. Although the targeted elimination of malignant cells is an elegant concept, there are numerous practical challenges that limit conjugates' therapeutic use, including inefficient cellular uptake, low cytotoxicity, and off-target effects. During the preparation of immunoconjugates by chemical synthesis, the choice of the hinge component joining the two building blocks is of paramount importance: the conjugate must remain stable in vivo but must afford efficient release of the toxic moiety when the target is reached. Vast efforts have been made, and the present article reviews strategies employed in developing immunoconjugates, focusing on the evolution of chemical linkers.
Source: Toxins
Institution: University of Turin
Language: English
Subfield: Immunology
Open Access status: gold
Estimated APC paid: $3,258
OpenAlex ID: W2021960694
FWCI: 0.603
Cites: 160
Cited by: 174
Related to: 10